EA200401423A1 - Пиперазинбензотиазолы, используемые в качестве средств для лечения церебральных ишемических расстройств или расстройств цнс - Google Patents
Пиперазинбензотиазолы, используемые в качестве средств для лечения церебральных ишемических расстройств или расстройств цнсInfo
- Publication number
- EA200401423A1 EA200401423A1 EA200401423A EA200401423A EA200401423A1 EA 200401423 A1 EA200401423 A1 EA 200401423A1 EA 200401423 A EA200401423 A EA 200401423A EA 200401423 A EA200401423 A EA 200401423A EA 200401423 A1 EA200401423 A1 EA 200401423A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- disorders
- piperizinbenzothiazoles
- cerebral ischemic
- treat cerebral
- cns
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение относится к пиперазинбензотиазоловым производным, а в частности, к их применению для лечения и/или профилактики церебральных ишемических расстройств или расстройств ЦНС. Настоящее изобретение также относится к способам получения указанных соединений.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02100417 | 2002-04-25 | ||
PCT/EP2003/004323 WO2003091249A1 (en) | 2002-04-25 | 2003-04-25 | Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200401423A1 true EA200401423A1 (ru) | 2005-04-28 |
EA009682B1 EA009682B1 (ru) | 2008-02-28 |
Family
ID=29265991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200401423A EA009682B1 (ru) | 2002-04-25 | 2003-04-25 | Пиперазинбензотиазолы, используемые в качестве средств для лечения церебральных ишемических расстройств или расстройств цнс |
Country Status (23)
Country | Link |
---|---|
US (1) | US7314878B2 (ru) |
EP (1) | EP1501828B1 (ru) |
JP (1) | JP4523289B2 (ru) |
KR (1) | KR100948469B1 (ru) |
CN (1) | CN1310911C (ru) |
AT (1) | ATE383356T1 (ru) |
AU (1) | AU2003233067B2 (ru) |
BR (1) | BRPI0309594A8 (ru) |
CA (1) | CA2481763C (ru) |
CY (1) | CY1107204T1 (ru) |
DE (1) | DE60318567T2 (ru) |
DK (1) | DK1501828T3 (ru) |
EA (1) | EA009682B1 (ru) |
ES (1) | ES2297165T3 (ru) |
HK (1) | HK1075664A1 (ru) |
IL (2) | IL164796A (ru) |
MX (1) | MXPA04010474A (ru) |
PT (1) | PT1501828E (ru) |
RS (1) | RS51407B (ru) |
SI (1) | SI1501828T1 (ru) |
UA (1) | UA78035C2 (ru) |
WO (1) | WO2003091249A1 (ru) |
ZA (1) | ZA200408023B (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78035C2 (en) | 2002-04-25 | 2007-02-15 | Applied Research Systems | Piperazine benzothiazole for treatment of cerebral ischemic disorders or cns disorders |
CA2534314C (en) * | 2003-09-12 | 2012-11-13 | Applied Research Systems Ars Holding N.V. | Benzothiazole derivatives for the treatment of diabetes |
WO2005118543A1 (ja) * | 2004-06-03 | 2005-12-15 | Ono Pharmaceutical Co., Ltd. | キナーゼ阻害薬およびその用途 |
US7838522B2 (en) | 2004-11-17 | 2010-11-23 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
EA011614B1 (ru) * | 2004-11-17 | 2009-04-28 | Арес Трейдинг С.А. | Препараты бензотиазола и их применение |
KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 jnk 억제제 |
BRPI0613042A2 (pt) * | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
WO2008125518A2 (en) * | 2007-04-17 | 2008-10-23 | Merck Serono S.A. | Process for the preparation of piperazine benzothiazoles |
CN102015689B (zh) * | 2008-05-16 | 2014-01-08 | 霍夫曼-拉罗奇有限公司 | Jnk的抑制剂 |
KR101800916B1 (ko) * | 2010-06-04 | 2017-11-23 | 에프. 호프만-라 로슈 아게 | Jnk 억제제로서 유용한 2-아미노-피리미딘 유도체 |
US8471027B2 (en) * | 2011-04-06 | 2013-06-25 | Hoffmann-La Roche Inc. | Adamantyl compounds |
WO2014114186A1 (zh) * | 2013-01-24 | 2014-07-31 | 山东亨利医药科技有限责任公司 | Jnk抑制剂 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4153574B2 (ja) | 1997-09-10 | 2008-09-24 | トーアエイヨー株式会社 | 新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤 |
EP1110957A1 (en) * | 1999-12-24 | 2001-06-27 | Applied Research Systems ARS Holding N.V. | Benzazole derivatives and their use as JNK modulators |
EP1193256A1 (en) | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins |
UA78035C2 (en) | 2002-04-25 | 2007-02-15 | Applied Research Systems | Piperazine benzothiazole for treatment of cerebral ischemic disorders or cns disorders |
-
2003
- 2003-04-25 UA UA20041008647A patent/UA78035C2/uk unknown
- 2003-04-25 WO PCT/EP2003/004323 patent/WO2003091249A1/en active IP Right Grant
- 2003-04-25 MX MXPA04010474A patent/MXPA04010474A/es active IP Right Grant
- 2003-04-25 EA EA200401423A patent/EA009682B1/ru not_active IP Right Cessation
- 2003-04-25 KR KR1020047016871A patent/KR100948469B1/ko not_active IP Right Cessation
- 2003-04-25 IL IL164796A patent/IL164796A/en not_active IP Right Cessation
- 2003-04-25 AU AU2003233067A patent/AU2003233067B2/en not_active Ceased
- 2003-04-25 PT PT03727365T patent/PT1501828E/pt unknown
- 2003-04-25 JP JP2003587807A patent/JP4523289B2/ja not_active Expired - Fee Related
- 2003-04-25 DE DE60318567T patent/DE60318567T2/de not_active Expired - Lifetime
- 2003-04-25 DK DK03727365T patent/DK1501828T3/da active
- 2003-04-25 SI SI200331114T patent/SI1501828T1/sl unknown
- 2003-04-25 ES ES03727365T patent/ES2297165T3/es not_active Expired - Lifetime
- 2003-04-25 AT AT03727365T patent/ATE383356T1/de active
- 2003-04-25 IL IL16479603A patent/IL164796A0/xx unknown
- 2003-04-25 US US10/511,438 patent/US7314878B2/en not_active Expired - Lifetime
- 2003-04-25 CA CA2481763A patent/CA2481763C/en not_active Expired - Fee Related
- 2003-04-25 CN CNB03814493XA patent/CN1310911C/zh not_active Expired - Fee Related
- 2003-04-25 BR BRPI0309594A patent/BRPI0309594A8/pt not_active IP Right Cessation
- 2003-04-25 RS YUP-928/04A patent/RS51407B/en unknown
- 2003-04-25 EP EP03727365A patent/EP1501828B1/en not_active Expired - Lifetime
-
2004
- 2004-10-05 ZA ZA2004/08023A patent/ZA200408023B/en unknown
-
2005
- 2005-11-10 HK HK05110023A patent/HK1075664A1/xx not_active IP Right Cessation
-
2008
- 2008-02-18 CY CY20081100199T patent/CY1107204T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107204T1 (el) | Πιπεραζινοβενζοθειαζολια ως ουσιες για την θεραπευτικη αντιμετωπιση εγκεφαλικων ισχαιμικων διαταραχων ή διαταραχων του κνς | |
IS6436A (is) | Pýrrólidín afleiður sem hringlaga AMP-sértækir fosfódíesterasa hindrarar | |
DK1242415T3 (da) | 3-thiazol-4-yl-pyrolidinderivater som AMP-specifikke phosphodiesteraseinhibitorer | |
CY1113306T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
ATE524169T1 (de) | Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit | |
NO20060278L (no) | Piperazinderivater og fremgangsmater for anvendelse | |
HK1054039A1 (en) | Substituded beta-carbolines | |
NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
HK1080467A1 (en) | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders | |
DE602004012578D1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
EP4100403A4 (en) | 3-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONINERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | |
DK1463735T3 (da) | Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider | |
BR0209541A (pt) | Uso das imidazotriazinonas 2-fenil-substituìdas | |
TW200612940A (en) | Substituted tetrahydroisoquinolines as mmp inhibitors, process for their preparation and their use as medicament | |
ATE297391T1 (de) | Indolderivate zum gebrauch in der behandlung von zns-störungen | |
NO20050146D0 (no) | N,N-disubstituerte diazocykloalkaner nyttige i behandling av CNS-forstyrrelser grunnet serotonergisk dysfunksjon | |
NO20053247D0 (no) | Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt. | |
DE60103761D1 (de) | Indolderivate zum gebrauch in der behandlung von zns-störungen | |
ATE412633T1 (de) | Piperazinderivate von alkyloxindolen | |
DE602004010186D1 (de) | Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2 | |
DE60102471D1 (de) | Indolderivate zur verwendung in der behandlung von zns-störungen | |
EA200200750A1 (ru) | Новое терапевтическое применение еноксапарина | |
NO20053612L (no) | 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Registration of transfer of a eurasian patent by assignment | ||
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |